Eugia US LLC recalls Dexamethasone Sodium Phosphate injection USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.
- Products
-
- Dexamethasone Sodium Phosphate injection USP
- Company
- Eugia US LLC
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 70,125 vials
- About this recall
- Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30